drugset / Trial / NCT00124072

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine

NCT00124072

Phase 3 Completed 12064 enrolled University of Oxford Merck Sharp & Dohme LLC · collab
RandomizedFactorialQuadruple-blindPrevention

Summary

SEARCH is a randomised, double-blind, multi-centre United Kingdom (UK) trial of 12,064 patients with myocardial infarction (MI) prior to study entry which aims to demonstrate whether a more intensive cholesterol lowering regimen using 80 mg simvastatin daily produces a larger and worthwhile reduction in cardiovascular events compared with a standard 20 mg daily regimen and whether reducing blood homocysteine levels with a daily dose of folic acid 2 mg + vitamin B12 1 mg compared with matching placebo produces a worthwhile reduction in vascular disease.

Timeline

Start
1998-07
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simvastatin Small molecule 20 mg
Comparator Simvastatin Small molecule 80 mg